为您找到相关结果约500个

你是不是要搜索 期刊T2DM合并肥胖的HFpEF 点击跳转

Clinical characteristics of T2DM patients diagnosed with HFpEF: An Indian pilot survey

Real-World Risk Indicators of Impaired Awareness of Hypoglycemia in T2DM (InHypo-DM Study)

HFpEF: SGLT-2 even without Diabetes

Di-(2-ethylhexyl) phthalate-induced hepatotoxicity exacerbated type 2 diabetes mellitus (T2DM) in femalepubertal T2DM mice

The association between microvascular complication in T2DM with HFpEF patients attending Hospital Al-Sultan

T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients

Real-World Evidence that Impaired Awareness of Hypoglycemia Increases Severe Hypoglycemia Rates in T2DM(InHypo-DM Study)

ALIROCUMAB ADD-ON THERAPY VERSUS CONTROL IN INDIVIDUALS WITH TYPE 2 DM AND ASCVD: ODYSSEY DM-DYSLIPIDEMIAAND DM-INSULIN

Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF

Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from theCHART-2 Study

T-cadherin deficiency increases vascular vulnerability in T2DM through impaired NO bioactivity

Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relativeswith T2DM

PREVELANCE OF CVD AMONG TYPE 2 DM PATIENTS

Gut microbiota influence in type 2 diabetes mellitus (T2DM)

HLA-DM MEDIATES PERMISSIVENESS OF T-CELL ALLOREACTIVITY TO HLA-DPB1

为您找到相关结果约500个

共500条页码: 1/34页15条/页